Logo image of GBTG

GLOBAL BUSINESS TRAVEL GROUP (GBTG) Stock Fundamental Analysis

NYSE:GBTG - New York Stock Exchange, Inc. - US37890B1008 - Common Stock - Currency: USD

6.315  +0.13 (+2.02%)

Fundamental Rating

2

Overall GBTG gets a fundamental rating of 2 out of 10. We evaluated GBTG against 133 industry peers in the Hotels, Restaurants & Leisure industry. GBTG has a bad profitability rating. Also its financial health evaluation is rather negative. While showing a medium growth rate, GBTG is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

In the past year GBTG has reported negative net income.
GBTG had negative earnings in each of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: GBTG reported negative operating cash flow in multiple years.
GBTG Yearly Net Income VS EBIT VS OCF VS FCFGBTG Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 200M -200M -400M -600M

1.2 Ratios

GBTG's Return On Assets of -1.16% is on the low side compared to the rest of the industry. GBTG is outperformed by 68.42% of its industry peers.
GBTG has a Return On Equity (-3.93%) which is in line with its industry peers.
GBTG has a Return On Invested Capital (4.45%) which is comparable to the rest of the industry.
Industry RankSector Rank
ROA -1.16%
ROE -3.93%
ROIC 4.45%
ROA(3y)-2.05%
ROA(5y)-8.27%
ROE(3y)-11.6%
ROE(5y)-26.03%
ROIC(3y)N/A
ROIC(5y)N/A
GBTG Yearly ROA, ROE, ROICGBTG Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 2M 4M 6M

1.3 Margins

GBTG has a Operating Margin of 6.66%. This is comparable to the rest of the industry: GBTG outperforms 41.35% of its industry peers.
In the last couple of years the Operating Margin of GBTG has declined.
GBTG has a Gross Margin of 60.85%. This is in the better half of the industry: GBTG outperforms 72.93% of its industry peers.
In the last couple of years the Gross Margin of GBTG has remained more or less at the same level.
Industry RankSector Rank
OM 6.66%
PM (TTM) N/A
GM 60.85%
OM growth 3YN/A
OM growth 5Y-12.48%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y17.04%
GM growth 5Y0.55%
GBTG Yearly Profit, Operating, Gross MarginsGBTG Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 60 -60

2

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), GBTG is destroying value.
Compared to 1 year ago, GBTG has more shares outstanding
The number of shares outstanding for GBTG has been increased compared to 5 years ago.
Compared to 1 year ago, GBTG has a worse debt to assets ratio.
GBTG Yearly Shares OutstandingGBTG Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M
GBTG Yearly Total Debt VS Total AssetsGBTG Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.2 Solvency

GBTG has an Altman-Z score of 1.07. This is a bad value and indicates that GBTG is not financially healthy and even has some risk of bankruptcy.
GBTG has a worse Altman-Z score (1.07) than 63.16% of its industry peers.
A Debt/Equity ratio of 1.22 is on the high side and indicates that GBTG has dependencies on debt financing.
The Debt to Equity ratio of GBTG (1.22) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 1.22
Debt/FCF N/A
Altman-Z 1.07
ROIC/WACC0.6
WACC7.41%
GBTG Yearly LT Debt VS Equity VS FCFGBTG Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 500M -500M 1B

2.3 Liquidity

GBTG has a Current Ratio of 1.60. This is a normal value and indicates that GBTG is financially healthy and should not expect problems in meeting its short term obligations.
With a decent Current ratio value of 1.60, GBTG is doing good in the industry, outperforming 77.44% of the companies in the same industry.
GBTG has a Quick Ratio of 1.60. This is a normal value and indicates that GBTG is financially healthy and should not expect problems in meeting its short term obligations.
With a decent Quick ratio value of 1.60, GBTG is doing good in the industry, outperforming 78.95% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.6
Quick Ratio 1.6
GBTG Yearly Current Assets VS Current LiabilitesGBTG Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

4

3. Growth

3.1 Past

GBTG shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 46.43%, which is quite impressive.
GBTG shows a small growth in Revenue. In the last year, the Revenue has grown by 5.81%.
GBTG shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 2.72% yearly.
EPS 1Y (TTM)46.43%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%400%
Revenue 1Y (TTM)5.81%
Revenue growth 3Y46.99%
Revenue growth 5Y2.72%
Sales Q2Q%1.8%

3.2 Future

GBTG is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 43.99% yearly.
The Revenue is expected to grow by 6.89% on average over the next years.
EPS Next Y196.98%
EPS Next 2Y69.9%
EPS Next 3Y50.53%
EPS Next 5Y43.99%
Revenue Next Year0.81%
Revenue Next 2Y2.6%
Revenue Next 3Y4.09%
Revenue Next 5Y6.89%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
GBTG Yearly Revenue VS EstimatesGBTG Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 1B 2B 3B
GBTG Yearly EPS VS EstimatesGBTG Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 0.5 1 1.5

3

4. Valuation

4.1 Price/Earnings Ratio

GBTG reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
A Price/Forward Earnings ratio of 19.25 indicates a rather expensive valuation of GBTG.
Compared to the rest of the industry, the Price/Forward Earnings ratio of GBTG indicates a somewhat cheap valuation: GBTG is cheaper than 60.15% of the companies listed in the same industry.
When comparing the Price/Forward Earnings ratio of GBTG to the average of the S&P500 Index (21.27), we can say GBTG is valued inline with the index average.
Industry RankSector Rank
PE N/A
Fwd PE 19.25
GBTG Price Earnings VS Forward Price EarningsGBTG Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40 60

4.2 Price Multiples

GBTG's Enterprise Value to EBITDA ratio is in line with the industry average.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 11.16
GBTG Per share dataGBTG EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4

4.3 Compensation for Growth

GBTG's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
GBTG's earnings are expected to grow with 50.53% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y69.9%
EPS Next 3Y50.53%

0

5. Dividend

5.1 Amount

No dividends for GBTG!.
Industry RankSector Rank
Dividend Yield N/A

GLOBAL BUSINESS TRAVEL GROUP

NYSE:GBTG (6/24/2025, 2:59:51 PM)

6.315

+0.13 (+2.02%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryHotels, Restaurants & Leisure
Earnings (Last)05-06 2025-05-06/bmo
Earnings (Next)08-04 2025-08-04/bmo
Inst Owners34.47%
Inst Owner Change1.35%
Ins Owners5.26%
Ins Owner Change1.92%
Market Cap3.02B
Analysts83.08
Price Target9.53 (50.91%)
Short Float %3.1%
Short Ratio5.26
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-259.23%
Min EPS beat(2)-516.67%
Max EPS beat(2)-1.8%
EPS beat(4)1
Avg EPS beat(4)-217.34%
Min EPS beat(4)-618.95%
Max EPS beat(4)268.07%
EPS beat(8)1
Avg EPS beat(8)-654.7%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-2.78%
Min Revenue beat(2)-3.91%
Max Revenue beat(2)-1.66%
Revenue beat(4)0
Avg Revenue beat(4)-3.18%
Min Revenue beat(4)-4.6%
Max Revenue beat(4)-1.66%
Revenue beat(8)2
Avg Revenue beat(8)-1.78%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-10.41%
PT rev (3m)-10.45%
EPS NQ rev (1m)24.33%
EPS NQ rev (3m)-48.82%
EPS NY rev (1m)24.53%
EPS NY rev (3m)3.78%
Revenue NQ rev (1m)0.88%
Revenue NQ rev (3m)-3.53%
Revenue NY rev (1m)0.73%
Revenue NY rev (3m)-4.16%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 19.25
P/S 1.24
P/FCF N/A
P/OCF N/A
P/B 2.7
P/tB N/A
EV/EBITDA 11.16
EPS(TTM)-0.21
EYN/A
EPS(NY)0.33
Fwd EY5.2%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS5.08
BVpS2.34
TBVpS-1.18
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -1.16%
ROE -3.93%
ROCE 5.63%
ROIC 4.45%
ROICexc 5.51%
ROICexgc 20.15%
OM 6.66%
PM (TTM) N/A
GM 60.85%
FCFM N/A
ROA(3y)-2.05%
ROA(5y)-8.27%
ROE(3y)-11.6%
ROE(5y)-26.03%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5Y-92.96%
ROICexc growth 3YN/A
ROICexc growth 5Y-94.57%
OM growth 3YN/A
OM growth 5Y-12.48%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y17.04%
GM growth 5Y0.55%
F-ScoreN/A
Asset Turnover0.64
Health
Industry RankSector Rank
Debt/Equity 1.22
Debt/FCF N/A
Debt/EBITDA 4.01
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.6
Quick Ratio 1.6
Altman-Z 1.07
F-ScoreN/A
WACC7.41%
ROIC/WACC0.6
Cap/Depr(3y)56.67%
Cap/Depr(5y)46.07%
Cap/Sales(3y)4.81%
Cap/Sales(5y)5.22%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)46.43%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%400%
EPS Next Y196.98%
EPS Next 2Y69.9%
EPS Next 3Y50.53%
EPS Next 5Y43.99%
Revenue 1Y (TTM)5.81%
Revenue growth 3Y46.99%
Revenue growth 5Y2.72%
Sales Q2Q%1.8%
Revenue Next Year0.81%
Revenue Next 2Y2.6%
Revenue Next 3Y4.09%
Revenue Next 5Y6.89%
EBIT growth 1Y276.47%
EBIT growth 3YN/A
EBIT growth 5Y-10.1%
EBIT Next Year187.61%
EBIT Next 3Y51.61%
EBIT Next 5Y44.43%
FCF growth 1Y236.74%
FCF growth 3YN/A
FCF growth 5Y0%
OCF growth 1Y67.9%
OCF growth 3YN/A
OCF growth 5Y3.68%